The psychedelic brew from the Amazon, known for causing vivid hallucinations, could reduce compulsions in people with eating disorders, a new study finds Research on ayahuasca as a treatment for various psychological issues and traumas is becoming increasingly popular Ayahuasca may activate parts of the brain that help people to be more open to new experiences ...
Category: <span>Pharmaceutical Updates</span>
Post
‘I was like a zombie’: Singer with the same pain disease that has crippled Lady Gaga reveals she ditched the cocktail of drugs she was prescribed and was cured by a £9.95 cream
Liz Farrell, from County Wexford in Ireland, was diagnosed with fibromyalgia Lady Gaga is taking time out from touring after revealing she suffers from it Eventually, Liz, 40, couldn’t walk and took sick leave from her bank clerk job Found alternative to cocktail of drugs that caused memory loss and weight gain A woman who...
Post
New drug to supercharge immune cells in the fight against cancer
Killer T cells surround a cancer cell. A new cancer treatment with the ability to normalise tumour blood vessels and boost the body’s immune system has been developed by researchers from The University of Western Australia and the Harry Perkins Institute of Medical Research. Many tumours can become resistant to the body’s immune system...
Post
Statin use appears to reduce risk of serious bacterial bloodstream infection
New study published in Mayo Clinic Proceedings shows that statin use was associated with decreased risk of blood infection with Staphylococcus aureus acquired outside of a hospital Rochester, MN, October 2, 2017 – Users of statins, widely prescribed for prevention of cardiac disease, have a 27% lower risk of contracting a Staphylococcus aureus (S. aureus) bloodstream infection...
Post
Azathioprine appears to improve disease course in early Crohn’s
(HealthDay)—Long-term use of azathioprine (AZA) is associated with a better disease course in patients with early Crohn’s disease (CD), according to a study published online Sept. 22 in the Journal of Gastroenterology and Hepatology. Yun Qiu, from Sun Yat-sen University in China, and colleagues evaluated the impact of AZA on disease progression in a cohort of 190 patients with...
Post
Medication that treats parasite infection also has anti-cancer effect
Overview of In vivo pooled library screen of new therapeutic targets for human epithelial ovarian cancer : This is the diagram depicting the overview of in vivo loss-of-function library screens. First, human ovarian cancer cell line was lentivirally transduced with druggable pooled shRNA library or whole-genome CRISPR/Cas9 library, generating large pool of cells with knockdown...
Post
Stopping aspirin treatment raises cardiovascular risk by over a third
New research published in the journal Circulation suggests that interrupting long-term, low-dose aspirin treatment may increase the likelihood of a second stroke or heart attack. Researchers led by Johan Sundström, a professor of epidemiology at Uppsala University in Sweden, set out to examine the effect of stopping low-dose aspirin treatment on the odds of having a second heart attack or stroke. The American...
Post
Pill made from cellulose that absorbs water to swell up to 100 times its original size ‘can beat obesity’
The pill, called Gelesis100, is made from the vegetable extract cellulose It absorbs water and swells 100 times its original size and helps suppress hunger The treatment is expected to be made available to doctors within two years Doctors last night hailed a new pill that helps obese patients lose up to 10 per cent...
Post
Small intestine permeable peptides facilitate digestive tract absorption
Changing injected drugs into orally administered medications Biopharmaceuticals, medium- and high-molecular weight biologically active macromolecules, are not easily absorbed by the small intestine, the main organ responsible for gastrointestinal absorption, resulting in a bottleneck for oral administration type biopharmaceutical development. Now, researchers from Kumamoto University in Japan have found a new small intestine permeable peptide...
Post
New compound discovered in fight against inflammatory disease
A 10-year study by University of Manchester scientists for a new chemical compound that is able to block a key component in inflammatory illness has ended in success. The news follows last year’s discovery by Dr David Brough and his team that the drug mefenamic acid reversed memory loss and brain inflammation in a model of Alzheimer’s disease....